🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

MetLife Named to Fortune Magazine's List of the World's Most Admired Companies

Published 02/07/2024, 10:36 PM
MET
-

MetLife (NYSE:MET)

NEW YORK, NY / ACCESSWIRE / February 7, 2024 / MetLife, Inc. (NYSE:MET) today announced that it has been named to Fortune magazine's 2024 list of the "World's Most Admired Companies." This year's list included eight life insurers in the annual report card of the best-regarded companies.

Annually, Fortune partners with Korn Ferry (NYSE:KFY) to rank companies by their corporate reputation. Corporate executives, directors, and analysts are asked to rate enterprises in their own industry on nine criteria, from investment value and quality of management to financial soundness, social responsibility, and ability to attract talent.

"We bring our purpose to life by creating a virtuous circle of shared value for all our stakeholders," said MetLife President and CEO Michel Khalaf. "This recognition belongs to our employees who work every day to build a more confident future for our customers and communities around the world."

Additional details about the rankings are available at Fortune.com.

About MetLife

MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

Contact:

MetLife
Olivia Janicelli
(212) 578-3547
olivia.janicelli@metlife.com

View additional multimedia and more ESG storytelling from MetLife, Inc. on 3blmedia.com.

Contact Info:
Spokesperson: MetLife, Inc.
Website: https://www.3blmedia.com/profiles/metlife-inc
Email: info@3blmedia.com

SOURCE: MetLife, Inc.



View the original press release on accesswire.com

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.